Riedel, GernotKlein, JochenNiewiadomska, GrazynaKondak, ConstantinSchwab, KarimaLauer, DilyaraMagbagbeolu, MandySteczkowska, MartaZadrozny, MaciejWydrych, MalgorzataCranston, AnnaMelis, ValeriaSantos, Renato X.Theuring, FranzHarrington, Charles R.Wischik, Claude M.2021-01-302021-01-302020-03-31Riedel, G, Klein, J, Niewiadomska, G, Kondak, C, Schwab, K, Lauer, D, Magbagbeolu, M, Steczkowska, M, Zadrozny, M, Wydrych, M, Cranston, A, Melis, V, Santos, R X, Theuring, F, Harrington, C R & Wischik, C M 2020, 'Mechanisms of anticholinesterase interference with tau aggregation inhibitor activity in a tau-transgenic mouse model', Current Alzheimer Research, vol. 17, no. 3, pp. 285-296. https://doi.org/10.2174/15672050176662002241209261567-2050SCOPUS: 85085537249ORCID: /0000-0003-3737-8296/work/79061687ORCID: /0000-0001-7063-7136/work/96652488ORCID: /0000-0003-2250-3920/work/173415859https://hdl.handle.net/2164/15752AVAILABILITY OF DATA AND MATERIALS The data that support the findings of this study are available from the corresponding author [CMW], upon reasonable request. FUNDING This study was sponsored entirely by WisTa Laboratories Ltd. under the following grants: PAR1395, PAR1561, PAR1562, PAR1577 and PAR1763. The sponsor was involved in the design of the study; in the collection, analysis and interpretation of data; and in the writing of the report. The corresponding author had full access to all the data and had final responsibility for submission of the report for publication.121087597engTau aggregation inhibitorLeucomethylthioniniumMouse modelAlzheimer’s diseasetauopathyacetylcholinesterase inhibitor (AChEI)drug interactionsynaptic proteinsR Medicine (General)Clinical NeurologyNeurologyR1Journal article10.2174/1567205017666200224120926http://www.scopus.com/inward/record.url?scp=85085537249&partnerID=8YFLogxK173